Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious liver diseases, announced positive results from a phase 2 study evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback